Purpose We explored patient-perceived role in Bdecisionmaking^related to active treatment and palliation among African Americans receiving lung cancer care through a county safety-net system.
Introduction
Given low overall survival rates, treatment decisions in the weeks following lung cancer diagnosis are critical. The majority of lung cancers (57 %) are diagnosed in advanced stages; overall 5-year survival rates for small cell and nonsmall cell lung cancer are 6 and 18 %, respectively [1] . Outcomes are worse for African American patients who are often diagnosed at younger ages, with more advanced disease [2] [3] [4] . Such disparities have been well-documented through comparative studies with other populations.
However, research on understanding Bdecision-making^in the course of lung cancer care has largely developed independent of work theorizing interpersonal processes-dynamics between both patient and caregiver as well as between patient and provider-that may impact patient-physician relationships. Research suggests that involving the primary caregiver, spouse, or other family members can directly impact cancer treatment outcomes [5, 6] , but further work is needed to advance understanding of caregiver roles and effects in decisionmaking with respect to active treatment and palliation, as well as transitions to end-of-life care [7, 8] . Moreover, despite clear evidence of differences in care practices and disparities in outcomes among minority and underserved patients, studies have largely ignored how socioeconomic status or racial/ ethnic group status may affect decision-making processes [9, 10] . Studies suggest low socioeconomic status (SES) patients, including many African Americans, are disproportionately less likely to receive guideline-based treatment for their lung cancer [11] , raising questions about overall patient-physician communication, as well as the interpersonal processes involved in treatment decision-making itself. Studies of lung resection rates and of end-of-life (EOL) care find marked differences in rates of treatment choice and suggest that factors such as religiosity, physician-patient racial concordance, and information-sharing/communication during provider interactions may be contributing factors [12] [13] [14] .
In general, most patients with cancer report a desire for full information regarding prognosis [15, 16] . This desire for full information is consistent across patients with varying levels of desire to participate in decision-making, although the match between preferred role and actual participation varies [17] . African American cancer patients report higher information needs than non-Hispanic whites [18] but perceive receiving less information and support from their providers [19] and rate their quality of care less highly than whites [20] ; in other studies, black patients with cancer are also less likely to acknowledge having a terminal illness [21] .
Type and amount of medical information, as well as how it is transmitted by the provider to the patient, may have a direct effect on treatment decisions. Patients' beliefs, values, and attitudes create an additional level of interpretation of this medical information, leading clinical investigators to frame decision-making as a Bcommunication process^ [9] . Such clear communication has been shown to contribute to receiving care that accords with patient values [9] , although caregiver involvement can introduce additional complexity [7, 22, 23] . A patient's acknowledgment and understanding of his/ her illness has been associated with treatment decision-making, particularly in advanced cancer [24] . Ineffective or unsatisfactory communication may directly affect whether patients proceed with provider-recommended procedures. For example, compared with white patients, black patients were more likely to receive life-prolonging care, even after conversations about EOL care have occurred [25] , suggesting that key information was either inadequately conveyed or received.
Many patients and their caregivers perceive physician interactive styles differently and report difficulties in understanding what medical information has been provided [26] , further constraining their ability to make informed decisions with clinicians. In safety-net settings, such as county hospitals, that disproportionately serve under-and uninsured patients [27] , providers are further challenged by the need to care for patients with lower health literacy and fewer resources [28] . Together, these factors adversely impact patient-physician communication and patient understanding with the potential to decrease informed decision-making [29, 30] . Prior studies have neglected to examine how characteristics of this population may alter the course of patient-provider interactions and decision-making. In this study, we use a qualitative research design to elucidate the relationships between patientperceived role and decision-making in lung cancer care, drawing from serial interviews on the safety-net lung cancer treatment experience with African American patient-caregiver dyads.
Methods
Given established disparities in treatment and care for lung cancer experienced by African Americans, this hypothesis-generating study explored how social dynamics of patient-caregiver dyads might shape decisionmaking in the safety-net setting. We sought to apply anthropological methods of dyadic, ethnographic interviewing [31] [32] [33] to understand the experience of lung cancer care among African Americans treated at Parkland Health and Hospital System. Parkland is the publicly funded, integrated health system for all residents of Dallas County and is the sole provider for under-and uninsured patients seeking cancer treatment [34, 35] . This study was approved by the UTSW Institutional Review Board (STU112011-064).
Recruitment and data collection
The study team used electronic medical record (EMR) data abstraction and manual chart review to identify African American lung cancer patients who had completed at least one visit with their oncologist at the ambulatory oncology clinic within this county safetynet hospital system. All patients were approached in the clinic, and informed consent was obtained prior to participation in the study. One hundred patients (74 %) completed a staff-administered survey, during which time patients were asked to identify a primary caregiver-usually a spouse/partner or family member-and subsequently offered the opportunity to be contacted for a series of three joint interviews with their primary caregiver at a location of their choice.
Patients who agreed to be contacted (n=45; 43 %) were called by research staff within 1 week of survey completion. Interviews were scheduled with at least 2-5 months between each session to better understand how lung cancer treatment and progression impacts the patient-caregiver experience. To acknowledge their time, dyads were offered a $30 honorarium at the end of each session ($90 total for series completion). The study team developed an interview guide to probe patient and caregiver experiences of support and communication with both family members and medical providers over the course of active treatment and follow-up. A medical anthropologist with expertise in ethnographic methods (SL) conducted all interviews at individual patient homes across Dallas County. Patients and caregivers discussed multiple aspects of the lung cancer experience including initial diagnosis, discussions with their medical team, understanding of treatment success and prognosis, EOL care as relevant, as well as their relationship to each other and extended family (see Appendix: interview guide, questions for initial session).
Patients and their caregivers were contacted 6-8 weeks after the completion of the prior interview to schedule the next session; sessions were approximately 90 min each. Thirteen participants initiated dyadic interviews with a caregiver, nine dyads completed second interviews, and five dyads completed the full three-session series. Reasons for not completing the series included patient death, illness burden (e.g., loss of speech, etc.), and lost to follow-up at second or third contact. Several sessions were delayed due to hospitalization events. Thus, a total of 27 interview sessions were conducted with 13 dyads, resulting in over 40 h of interview data.
While almost equal numbers of male and female patients participated in interviews (6 women), all but one caregiver were female. Caregivers identified as spouse/partner (n=4), adult children (n=4), and other family members (n=5).
Data analysis
Interviews were captured using a digital audio recorder and transcribed by a professional transcriptionist. Transcripts of each interview were coded in NVivo 9 (QSR International, AU) by a masters-level qualitative analyst using an inductive text-driven approach to thematic content analysis [36, 37] . Data were analyzed based on conversation, i.e., each dyad was treated as its own unit of analysis. After the first four interviews were completed, the research team undertook iterative readings of transcripts to produce an initial list of codes as they emerged. We then applied these broader codes to the first set of interviews. The research team discussed emergent themes and consolidation of codes after more than half of the interviews had been analyzed [38, 39] . We developed additional codes as they emerged during analysis of the second and third interview sessions. By conducting these latter interviews concurrently with transcript analysis, the interviewer was able to explore new ideas during interviews as new themes were identified. Once the second half of the interviews was analyzed and our coding structure was finalized, the analyst reanalyzed the first set of transcripts, applying the new codes generated by the later interviews.
We assessed for sociodemographic and clinical differences between the interview dyads and the larger group of survey respondents using Fisher's exact tests. Statistical analyses were conducted using SAS software, version 9.3 (SAS Institute Inc., Cary, NC).
Results
Approximately equal numbers of men and women were enrolled in the cohort; most patients ranged from 50 to 70 years of age (72 %); 46 % were surveyed within 6 months of diagnosis. Over half of patients reported receiving less than a high school education (53 %). Based on age, sex, education, marital status, smoking history, and time since diagnosis, the dyadic interview participants (n= 13) were representative of the overall study cohort of African American lung cancer patients receiving care through this safety-net hospital system (n=87; all Fisher's exact tests were nonsignificant, see Table 1 ). Our analysis identified four major themes in the experience of lung cancer care, which we have grouped as: challenges to effective communication, caregivers as advocate and facilitator, lack of understanding of prognosis and outcomes, and clinicians make decisions. Selected additional quotations are included in Table 2 by theme.
Challenges to effective communication
Our findings indicated that healthcare communication between patients, caregivers, and clinicians is constrained by use of medical language. However, our interviews revealed that while such challenges commonly frustrate patients and their family, these frustrations were rarely expressed to providers during their clinical visits. Patients and caregivers described these interactions with providers in the following ways (see also Mhm. 'Cause really I ain't had a chance to sit down and talk with nobody one on one. It's always been a group [of providers]. Not one on one. Then you talk to a group, like you say, this one will say something then this one will say something. Patients may have unexpressed concerns or anxieties but seem to consistently avoid questions and discussions related to prognosis and progression. As in the first case below, the patient seems to express the expectation that the provider would initiate a discussion about disease progression based on the provider's expert knowledge and judgment.
They ain't saying nothing about nothing worsening, you know, getting bad or nothing… I believe if something was bad, they'll tell me. (Patient, second interview dyad 121) Never even asked [oncologist]… how long do you have?…-I've never asked him that. I don't feel that's a question that needs to be asked right now. (Girlfriend, first interview, dyad 111)
Caregivers as advocate and facilitator
Caregivers discussed the need to be present for medical visits and other interactions in clinic settings to help their patient family member to understand what information was provided by the medical team or to explain procedures as they happen. Caregivers assert that simply Bbeing there, as well as providing instrumental support, for example, by taking notes during medical appointments, is a core component of the caregiver role, even if the clinical discussion itself is difficult for the caregiver to understand (see also Table 2.4).
Every doctor, every nurse, whatever you were, I was seeing. I'm writing your name and I want to know… what department are you in, and I could tell him, BOkay now this one here, I tell him remember the one with the glasses that wear her little hair up like that, okay they're from this department and they going to do this. That one over there, he's going to give you medicine, this one here he's going to do that,^…he got used to them. (Daughter, first interview, dyad 48) Patients and their caregivers express engagement in cancer treatment through adherence. By attending treatment appointments, maintaining the recommended diet, and taking medications, even when difficult or painful, patients and caregivers report active adherence to their current treatment regimen (see also We are more or less on track-I think everybody's on the same page… Seems like everything seems to be working just fine for us. Our appointments, we haven't missed a one, day or night. His medication, we're up to date on that. (Patient's girlfriend, first interview, dyad 111)
Lack of understanding of prognosis and outcomes
While patients and their caregivers describe deep engagement in lung cancer care, they expressed a concurrent lack of understanding of prognosis and treatment outcomes in most cases (see also In this excerpt, an adult daughter attributed her father's limitations to age and rationalized shortness of breath as a logical consequence of resection. Over the remainder of the interview, her comments show no indication of understanding the implications of possible disease progression. Many interview participants also express distinct lack of understanding of disease stage:
From what he had told me earlier, it was like a phase 3 and I don't know what that is, you know stage 3… they had done the biopsy and he told me it was like phase 3. But I want to know what that is in laymen's terms, what does that mean? I say when I go this week to the doctor, I'm gonna ask all kinds of questions and stuff. (Patient, second interview, dyad 94) But, I guess that was how I was looking through the medical record and one sheet, somebody wrote down stage four and so well I said, well where did that come from? I don't know nothing 'bout no stage four… So I said maybe that is just a misunderstanding… So well maybe that's just, you know an error. How far many stages do they go? (Wife, first interview, dyad 45) While patients expressed positive attitudes regarding treatment options in general, we found that in cases where surgery was offered or discussed, patients expressed notable fears or concerns about Bcutting,^as other studies have previously reported (see also I was so worried about being cut though, I did not want to be cut at all, that I was grateful for because I didn't want to be cut…Because it's like every time somebody gets cut, it go like that *snap* and they say like the air hits and it spreads. I don't know if that's true or what but I do know that the majority of people that get cut, especially for lung cancer, they don't make it. (Patient, second interview, dyad 78)
Clinicians make decisions
In our interview discussions, patients and their caregivers did not frame their treatment experience in terms of Bdecision-making.^Rather, when they spoke about their treatment, patients framed the care they received in terms of decisions their clinicians had made for them (see also Table 2 .10-2.11).
They've been really straightforward with me you know. So it's no decision to really make, but the decision to make is well if you got a cure, then I'm willing to try with you, you know to where with you to see if that cure Patients and their caregivers spoke in detail about their experience of care, many in the context of religious beliefs that reveal a more complex dynamic within the treatment milieu than is often conveyed in the simple terms of active or passive patient roles. A patient initially presented with a surgical treatment option explains how he planned to choose chemotherapy instead, only to return to his appointment to learn that surgery was no longer an option:
Hell, it wasn't even a 30-minute surgery…. It sounded good-oh it was coming at me and you know, in my thinking like-wow-but I prayed on it and the next day, I went back for the decision. So my decision was that no-cause I had either surgery or another month of chemo and we can wash it away. So I was going in strong-well, I'll tell you this, I'm taking the chemo point blank. That's the way-we'll let it wash away and I didn't have to say anything 'cause their decision was already made because then the doctor said [surgery] was a waste of time… (Patient, third interview, dyad 126)
In this case, the patient had been reluctant about a surgical route and enthusiastic about chemotherapy, taken with the notion of Bwashing out cancer.^But the interview did not convey knowledge about the surgical oncologist consult regarding implications of a small lesion, its location, and operability. Instead, framed by the patient's appeal to prayer, the decision appeared to have been made. This interaction exemplifies the complexity of patient-provider decision-making processes, where the outcome was not incongruent with the patient's preference; but it was not truly a patient-driven decision. Now why should I be in here bitter side and well, me-that's why I didn't go that way. I went the way that I know that okay, this is how we going to do it and the doctor's thought I was crazy, but this is the way we gonna do it because I had a God that telled me this is the way I'm gonna do it. (Patient, third interview, dyad 126)
We found that patient accounts did not reflect transparent moments of patient decision-making; rather, they reflect nuanced conversations between clinicians and patients who trust them to provide what they need. Indeed, that patient recounts:
So [the doctor] say, Bwhat I gotta do is that I'm gonna have to send you for a PET scan^and I say, Bwhy do I have to take a PET scan?^because, you know, she said I was talking about, you know, you have two options and I said, Bwhat's the options?^She say, BWell, we can have surgery and take it right on out, or you can just do two more treatments, two more months of treatment of chemo^and I say, BWell, I'm really tired of chemob u t , y o u k n o w, t h a t w a s j u s t m y t h in k i n g then…..
[doctor] sat down and explained it to me first. After she gave me the good news, how it had shrunk and then she, she sat down and she told me. …. that it was still up to me, what I wanted I want to do because she really had no, Bno, don't do, I don't think you all need to cut him.^And it wasn't there yet; it was just throwing it out there that. But I had to still do the PET scan, so we could see it, where it was at. And so she set me up with them right away (Patient, second interview, dyad 126) Decisions about receipt of cancer care return to issues of adherence that follow from understanding the guidance doctors give. Further, patients are aware of the broader context of county safety-net care in which conversations with clinicians occur.
That's the number one thing is to understand what [doctors are] saying and if you do understand what they're saying, go about what they tell you to do. I mean if they-they're not gonna tell you to do anything wrong. And even if they're telling you, it's for the benefit of your health, not for theirs. And just go to all of your appointments. Don't miss any. You can't. There's other people out there that's sick that need that appointment. You've got it, they've set it for you, be there. (Patient, first interview, dyad 111)
Discussion
Our study data suggest that physician-patient communication and decision-making among safety-net patients differ from how such processes play out in mainstream populations among whom prior studies have been conducted. While this cohort of African American patients generally liked and respected their physicians, our interviews reveal that patients and their caregivers are often unsatisfied with clinician interactions and report uncertainty about their limited medical knowledge of the relationship between disease stage and treatments [44] . In this cohort of safety-net patients, however, we found this frustration was rarely communicated to their providers during clinic visits. This is a notable finding among low-income, minority, and under-and uninsured patients where the social context of care may increase patient desire to avoid being perceived as Bdifficult,^resulting in more passive patient behaviors [45] .
While initial conversations with patients and their caregivers would seem to indicate relative understanding of their illness, our extended interviews suggest a need for greater nuance. In some cases, we found that failure to understand progression and disease course (e.g., metastasis) was associated with misunderstanding the relevance of surgical intervention for resectable versus unresectable disease [12] . Patients or caregivers repeatedly endorsed the idea that Bcutting^contrib-utes to disease progression, as prior studies of African American patients have also reported [40, 43] . Thus, when clinicians indicated patients would not receive surgery, patient dyads often expressed relief, apparently, at having avoided an invasive procedure. Only one patient dyad indicated they understood that surgery was not an option because their cancer was inoperable or surgery likely ineffective at this point in their disease course. Our interview data suggest that superficial reports of patient understanding of disease, in truth, only reflect increased familiarity with the treatment regimen that patients were currently receiving and consequent compliance. This finding corresponds to recent studies reporting varied understanding of disease course, treatment, and prognosis [46] [47] [48] [49] .
Nationally, low rates of overall survival for advanced lung cancer make clear communication all the more urgent, especially among disparities populations that are more frequently diagnosed at later stages. In populations with lower health literacy, talk of Bstage^itself may be misleading. Patients and their families ask, how long until the next stage? How many stages are there? Few understand, and their clinicians may not explain, that stage is an artifact of the diagnostic process, used to identify an appropriate treatment regimen, but do not understand that a patient's lung cancer does not progress in units of ordered time from one stage to a later stage.
Our findings point to the need for further studies to explore decision-making across different SES populations [50] . Our study raises concerns about how clinicians conceptualize the process of patient Bdecision-making^among safety-net populations in particular, where understanding of prognosis may be absent or confused [48, 51] . Our cohort of patients strongly agreed with the importance of keeping appointments and complying with physician recommendations. However, our interview findings suggest that patients did not perceive conversations in which clinicians raised types of treatment as discussions of actual Btreatment options.^Patients and their families rarely framed any of their experience in terms of patient Bchoices.^In contrast to some prior studies of African American cancer patients [52] , our patient dyads reflected the belief that decisions about treatment rest with their clinical team. Our interview data do not support the idea that safety-net patients make clear distinctions between clinician recommendations about treatment and clinician decisions-to-treat. Thus, in contrast to the premise of many prior decision-making studies, clinician communication styles intended to preserve patient autonomy may not be optimal for underserved patients at every stage of their illness [53, 54] .
Our findings have direct implications for decision-making because, absent a clear understanding of stage and relation to prognosis, many patients we spoke to were unaware of relative likelihood of decompensation; unprepared to understand palliation as opposed to curative treatments; and, consequently, had not prepared for family planning about end-of-life preferences such as hospice, etc. End-of-life and palliative care studies have extensively documented how the specter of mortality can inhibit patient-provider conversations about prognosis and treatment options [18, [55] [56] [57] . Indeed, our patient dyads themselves struggled with these topics and conversation was awkward, even uncomfortable, for several patients and caregivers, despite iterative, extended interview sessions during which the investigator was otherwise able to establish significant rapport. We acknowledge, however, that we were interviewing patients in active treatment and followup as opposed to during explicit hospice or palliative care when patients would be more aware of EOL-related decisions that might result in greater emphasis on patient control [52, 58] . Similarly, religious belief and use of prayer introduced factors that could enrich models of interpersonal decisionmaking beyond the patient-provider binary. Among patients, such as those seeking care in safety-net settings, who may not think about their care experience in terms of specific choices, clinicians who speak directly with patients about their spiritual beliefs can create new opportunities to clarify patient expectations of the care they are receiving [59] .
Limitations of this study include a small sample size and the inability for some dyads to be available for all three interviews due to prior caregiver commitments or patient illness. The resource intensity of conducting ethnographic interviews with economically disadvantaged and actively ill patients stipulated a relatively small study sample. To address this, we sought to survey every African American lung cancer patient treated at Parkland using validated measures, both to establish a baseline understanding of psychosocial factors and to demonstrate that the subsample invited to interviews was representative of the overall population of African American lung cancer patients treated at the county hospital. Although we offered gift cards to each dyad, we do not believe additional financial incentive would necessarily decrease attrition. Many people who seek care in safety-net settings, like Parkland, hold hourly employment on unstable schedules, often for multiple employers. Thus, the inability to take time off work rather than compensation for research participation poses a challenge for studies in this population.
Our study is the first, to our knowledge, to explicitly focus on the lung cancer experience of African American patients in a safety-net setting. There is a paucity of studies exploring decision-making issues among lower-SES and minority patients like those we report on here [16, 17, 60] . Although there may be particular racial/ethnic dimensions to patient-clinician communication needs, it is important to note that race construct-specific cultural issues did not emerge from these iterative interviews with our patients and their caregivers, even when prompted. In this context, our study contributes to a very limited literature that has sought to explore whether socioeconomic status (SES, proxies including low educational attainment, low income, urban/teaching hospital) constitutes a stronger challenge than race or ethnicity to fostering robust patient-physician communication [60] [61] [62] [63] . Proxies for SES like income and education may mediate the association of race with quality of clinician communication [64] . Thus, while cultural group-specific framing may be important to how future interventions are tailored for delivery, the broad lack of patient knowledge about prognosis and treatment options we found suggests these SES-related factors may be more effective targets than other contributors specifically cast as racial or ethnic cultural attributes [4] .
Conclusion
While our participants almost uniformly expressed trust and confidence in their clinicians, our study findings suggest several practical considerations to improve clinician communication and, thereby, facilitate ability of lung cancer patients and their caregivers to make informed decisions concerning their course of care, even if the decision is to allow treating clinicians to determine that course. First, because many safety-net patients defer to their care team, clinicians should initiate conversations about diagnostic stage, prognosis, and disease progression. To ensure accurate understanding, clinicians should ask patients to repeat back what they know and what they think that means about what comes next for their care. To provide optimal care, clinicians should initiate discussion of palliative symptom management in parallel with curative treatments. Further, asking about spiritual beliefs creates opportunity to clarify patient expectations about treatment, as well as to convey clinician concern about an important dimension of patient life. Clear communication about these issues early in the course of treatment would encourage patients and their caregivers to articulate values and expectations, in advance of confronting the need to make decisions about end-oflife, comfort care, and appropriateness of hospice. Lack of understanding and consequent lack of discussion leave patients and family members unprepared should disease progress, directly impacting quality of care and the overall survivorship experience of lung cancer.
Our results call for future studies to clarify whether the lack of understanding of prognosis we identified reflects failure of clinician communication about prognosis, failure of patient comprehension, patient denial, or some combination of these factors-all of which may be further complicated by how patients perceive their role in decision-making, given the safety-net milieu. Dyadic ethnographic interviews detailing safety-net patient experiences of lung cancer care, thus, raise important questions about how clinicians, as well as researchers, conceptualize processes of informed decisionmaking in such vulnerable, underserved populations. Patient lack of knowledge of prognosis may impact perception of choice within the safety-net patient-clinician relationship. It follows that efforts to develop interventions seeking, for example, to increase rates of receipt of guideline-based care [65] or to improve clinical trial participation [66, 67] will need to account for these issues as they relate to decision-making in safety-net cancer care.
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